Opportunity Information: Apply for RFA DA 15 008
Apply for RFA DA 15 008
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "The National Drug Abuse Treatment Clinical Trials Network (UG1)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Jul 3, 2014 and posted on Jul 3, 2014.
- Applicants must submit their applications by Dec 3, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $15,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- Eligible applicants include: Public housing authorities/Indian housing authorities County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Special district governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Independent school districts Others (see text field entitled Additional Information on Eligibility for clarification) For profit organizations other than small businesses Native American tribal governments (Federally recognized) City or township governments State governments Small businesses Public and State controlled institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Foreign Institutions Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The National Drug Abuse Treatment Clinical Trials Network (CTN) (UG1) funding opportunity (RFA-DA-15-008) is a National Institutes of Health (NIH) cooperative agreement run through the National Institute on Drug Abuse (NIDA) to support clinical investigators who will help carry out a large, coordinated research effort focused on substance use disorders (SUD). The main purpose is to expand and strengthen the CTN so it can develop, test, and ultimately improve real-world interventions for the full range of substance misuse and SUD conditions, with an emphasis on approaches that can be used not only in specialty addiction programs but also in general medical settings where many patients first show up for care.
A central theme of the announcement is integration. NIDA is looking for applicants who can work in close partnership with healthcare providers, patients, and other stakeholders, and who can form practical, functioning alliances with practice-based research networks, especially in primary care and broader general medical systems. The idea is to build a pipeline from research to everyday clinical practice by designing studies that fit into routine healthcare workflows and produce evidence that clinicians and health systems can use to manage SUD alongside other medical and behavioral health conditions. In addition to primary care and general medicine, the CTN model also links to specialty addiction treatment settings, so research can address how patients move between levels of care and how coordinated, stepped, or collaborative care models can improve outcomes.
The FOA also highlights the role of community-based treatment providers. By expanding CTN partnerships, NIDA intends to create more opportunities for community SUD treatment organizations to evaluate integrated and collaborative models aimed at patients with higher-severity SUDs. In practical terms, that means testing interventions and service delivery strategies that go beyond a single clinic or setting, including models that coordinate medical care, addiction treatment, and supportive services, and that can be sustained in the kinds of organizations that treat large numbers of patients in real communities.
Because this is a cooperative agreement (UG1) rather than a standard grant, awardees should expect substantial scientific and programmatic involvement from NIH/NIDA. That typically implies a more team-based structure, shared responsibilities, and participation in network activities such as protocol development, common measures, quality assurance, data coordination expectations, and multi-site collaboration. The overall expected outcome is a set of high-integrity, evidence-based interventions and care strategies that can be deployed across healthcare and treatment systems to improve national health outcomes related to substance misuse and addiction.
From the administrative side, this was a discretionary funding opportunity with an estimated total funding amount of $15,000,000 and an award ceiling of $500,000. No cost sharing or matching was required. The opportunity was posted July 3, 2014, with an application closing date of December 3, 2014, and it was archived January 3, 2015. The CFDA number listed is 93.279 (Drug Abuse and Addiction Research Programs).
Eligibility was broad and included many types of domestic organizations such as state, county, city/township, and special district governments; tribal governments and tribal organizations; public and state-controlled institutions of higher education and private institutions of higher education; nonprofits (both with and without 501(c)(3) status); for-profit organizations (other than small businesses) as well as small businesses; independent school districts; public housing authorities; and other entities as further described in the FOA. The eligibility language also explicitly included various mission-focused institutions and organizations such as HBCUs, Hispanic-serving institutions, AANAPISIs, TCCUs, Alaska Native and Native Hawaiian-serving institutions, faith-based or community-based organizations, regional organizations, and eligible federal agencies. Foreign institutions and other non-U.S. entities were not eligible, and non-domestic components of U.S. organizations were not eligible; foreign components were not allowed under NIH policy as stated in the announcement.
The full announcement was available through the NIH grants guide at the link provided in the source material (http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-15-008.html), and general technical assistance for accessing the FOA was routed through the NIH Office of Extramural Research (OER) webmaster contact.
FAQs: National Drug Abuse Treatment Clinical Trials Network (CTN) (UG1) - RFA-DA-15-008
What is this funding opportunity?
This opportunity is the National Drug Abuse Treatment Clinical Trials Network (CTN) (UG1) cooperative agreement funding opportunity, RFA-DA-15-008, offered through the National Institutes of Health (NIH) and administered by the National Institute on Drug Abuse (NIDA).
What does CTN stand for, and what is it focused on?
CTN stands for the National Drug Abuse Treatment Clinical Trials Network. It supports a large, coordinated research effort focused on substance use disorders (SUD), with the goal of developing and testing interventions that can improve real-world care.
What is the primary purpose of this FOA?
The main purpose is to expand and strengthen the CTN so it can develop, test, and improve real-world interventions for the full range of substance misuse and SUD conditions, especially interventions that work in both specialty addiction programs and general medical settings.
What kinds of settings does NIDA want this research to work in?
The FOA emphasizes approaches that can be used not only in specialty addiction treatment programs, but also in primary care and general medical settings where many patients first seek care.
What is a central theme of the announcement?
Integration is a central theme. NIDA is looking for applicants who can integrate substance use disorder research and care strategies into routine healthcare workflows and broader medical systems.
What types of partnerships are expected?
Applicants are expected to work in close partnership with healthcare providers, patients, and other stakeholders, and to form practical, functioning alliances with practice-based research networks, particularly in primary care and general medical systems.
What is meant by building a "pipeline" from research to clinical practice?
It refers to designing studies that fit into day-to-day healthcare operations and generate evidence that clinicians and health systems can use to manage SUD alongside other medical and behavioral health conditions.
Does the FOA involve specialty addiction treatment settings too?
Yes. The CTN model links general medical settings with specialty addiction treatment settings so research can address how patients move between levels of care and how coordinated, stepped, or collaborative care models can improve outcomes.
How does the FOA describe the role of community-based treatment providers?
The FOA highlights community-based treatment providers as important partners. By expanding CTN partnerships, NIDA aims to create more opportunities for community SUD treatment organizations to evaluate integrated and collaborative models for patients with higher-severity SUDs.
What kinds of interventions or service strategies are implied?
The FOA points to interventions and service delivery strategies that go beyond a single clinic or setting, including models that coordinate medical care, addiction treatment, and supportive services, and that can be sustained in organizations serving large numbers of patients in real communities.
What is a UG1 cooperative agreement, and how is it different from a standard grant?
This is a cooperative agreement (UG1), which means awardees should expect substantial scientific and programmatic involvement from NIH/NIDA. It typically involves a more team-based structure, shared responsibilities, and active participation in network-wide activities.
What kinds of network-wide responsibilities might awardees have?
Based on the FOA description, participation may include protocol development, use of common measures, quality assurance activities, meeting data coordination expectations, and working in multi-site collaborations.
What outcomes is NIDA expecting from this program?
The expected outcome is a set of high-integrity, evidence-based interventions and care strategies that can be deployed across healthcare and treatment systems to improve national health outcomes related to substance misuse and addiction.
How much funding was available under this opportunity?
The estimated total funding amount was $15,000,000.
What was the maximum award size?
The award ceiling listed was $500,000.
Was cost sharing or matching required?
No. The opportunity stated that no cost sharing or matching was required.
When was the opportunity posted and when did it close?
It was posted on July 3, 2014, and the application closing date was December 3, 2014.
Is this funding opportunity still open?
No. The listing indicates it was archived on January 3, 2015.
What is the CFDA number for this program?
The CFDA number listed is 93.279 (Drug Abuse and Addiction Research Programs).
Who was eligible to apply?
Eligibility was broad and included many types of domestic organizations, including various government entities, higher education institutions (public and private), nonprofits (with or without 501(c)(3) status), for-profit organizations (including small businesses and other-than-small businesses), independent school districts, public housing authorities, and other entities as described in the FOA.
Which government entities were included in eligibility?
Eligibility included state, county, city/township, and special district governments, as well as tribal governments and tribal organizations.
Were mission-focused institutions and community organizations explicitly included?
Yes. The eligibility language explicitly included HBCUs, Hispanic-serving institutions, AANAPISIs, TCCUs, Alaska Native and Native Hawaiian-serving institutions, faith-based or community-based organizations, regional organizations, and eligible federal agencies.
Are foreign institutions or non-U.S. entities eligible?
No. Foreign institutions and other non-U.S. entities were not eligible.
Are non-domestic components of U.S. organizations eligible?
No. Non-domestic components of U.S. organizations were not eligible.
Are foreign components allowed under this FOA?
No. The FOA states that foreign components were not allowed under NIH policy as described in the announcement.
Where could applicants find the full FOA?
The full announcement was available through the NIH grants guide at: http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-15-008.html
Where was technical assistance directed for accessing the FOA?
General technical assistance for accessing the FOA was routed through the NIH Office of Extramural Research (OER) webmaster contact.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: Wetland Restoration Assistance
Previous opportunity: PPHF 2014 Immunization HPV Roundtable Creating a National Network of Partners to Promote Cancer Prevention through Human Papillomavirus (HPV) Vaccination financed solely by 2014 Prevention and Public Health Funds
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DA 15 008
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DA 15 008) also looked into and applied for these:
| Funding Opportunity |
|---|
| Connectomes Related to Human Disease (U01) Apply for PAR 14 281 Funding Number: PAR 14 281 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Extracellular Vesicles in HIV/AIDS and Substance Abuse (R01) Apply for RFA DA 15 011 Funding Number: RFA DA 15 011 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
| Extracellular Vesicles in HIV/AIDS and Substance Abuse (R21) Apply for RFA DA 15 012 Funding Number: RFA DA 15 012 Agency: National Institutes of Health Category: Education Health Funding Amount: $2,000,000 |
| Innovative Research in Cancer Nanotechnology (IRCN) (U01) Apply for PAR 14 285 Funding Number: PAR 14 285 Agency: National Institutes of Health Category: Education Health Funding Amount: $450,000 |
| Centers of Cancer Nanotechnology Excellence (CCNEs) (U54) Apply for RFA CA 14 013 Funding Number: RFA CA 14 013 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Interventions for Youth who Misuse/Abuse Prescription Stimulant Medications in High School and/or College Attending Youth (U01) Apply for RFA DA 15 010 Funding Number: RFA DA 15 010 Agency: National Institutes of Health Category: Education Health Funding Amount: $1,000,000 |
| Arts Based Approaches in Palliative Care for Symptom Management (R01) Apply for PAR 14 294 Funding Number: PAR 14 294 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Cancer Intervention and Surveillance Modeling Network (CISNET) (U01) Apply for RFA CA 14 012 Funding Number: RFA CA 14 012 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| New Approaches to Synthetic Lethality for Mutant KRas Dependent Cancers (U01) Apply for PAR 14 314 Funding Number: PAR 14 314 Agency: National Institutes of Health Category: Education Health Funding Amount: $750,000 |
| Obesity and Asthma Awareness and Self Management (R01) Apply for PA 14 316 Funding Number: PA 14 316 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Limited Competition AIDS Malignancy Clinical Trials Consortium (UM1) Apply for RFA CA 14 502 Funding Number: RFA CA 14 502 Agency: National Institutes of Health Category: Education Health Funding Amount: $21,400,000 |
| Developing Interventions for Health Enhancing Physical Activity (R21/R33) Apply for PAR 14 321 Funding Number: PAR 14 321 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Training Modules to Enhance Data Reproducibility (R25) Apply for RFA GM 15 006 Funding Number: RFA GM 15 006 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Limited Competition International Agency for Research on Cancer (IARC) Monographs Program (U01) Apply for RFA CA 14 503 Funding Number: RFA CA 14 503 Agency: National Institutes of Health Category: Education Health Funding Amount: $859,000 |
| Advancing Interventions to Improve Medication Adherence (R21) Apply for PA 14 335 Funding Number: PA 14 335 Agency: National Institutes of Health Category: Education Health Funding Amount: $275,000 |
| NLM Grants for Scholarly Works in Biomedicine and Health (G13) Apply for PAR 14 339 Funding Number: PAR 14 339 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Self Management for Health in Chronic Conditions (R01) Apply for PA 14 344 Funding Number: PA 14 344 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Self Management for Health in Chronic Conditions (R21) Apply for PA 14 343 Funding Number: PA 14 343 Agency: National Institutes of Health Category: Education Health Funding Amount: $275,000 |
| Self Management for Health in Chronic Conditions (R15) Apply for PA 14 345 Funding Number: PA 14 345 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2015 and 2016 (P50) Apply for PAR 14 353 Funding Number: PAR 14 353 Agency: National Institutes of Health Category: Education Health Funding Amount: $2,300,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 15 008", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.